Thursday, November 12, 2026

USD/CNH Slides By 2% In The Last 10 Sessions

ViaNews Editorial Team

January 28, 2024

USD/CNH Slides By 2% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 2.01% for the last 10 sessions. At 13:11 EST on Sunday, 28 January, USD/CNH (USDCNH) is $7.18.

USD/CNH's yearly highs and lows, it's 0% down from its 52-week low and 0% down from its 52-week high.

News about

  • Eur/usd seen at 1.0700/1.0500 on a 6/12m horizon – danske bank. According to FXStreet on Friday, 26 January, "While we recognise that our Fed (first cut in March) and ECB (first cut in June) forecasts, all else equal, are positive for EUR/USD in H1, we believe that the broader pricing in the G10 could be more decisive for the cross, as we perceive current market expectations for rate cuts to be excessive.", "We still maintain our bias towards selling EUR/USD on rallies in the near term, and we forecast EUR/USD at 1.0700/1.0500 on a 6/12M horizon."
  • Eur/usd: the downside looks open to the 1.0790/1.0800 area – ING. According to FXStreet on Friday, 26 January, "The downside for EUR/USD looks open to the 1.0790/1.0800 area now and 1.0875/1.0900 looks like stronger resistance. "
  • Eur/usd weekly forecast: incremental trend lower persists as traders fret - 28 January 2024. According to DailyForex on Sunday, 28 January, "If the EUR/USD can sustain its current ratios and stay above the 1.08400 level this might be taken as a sign more buying is going to develop. ", "The currency pair may appear oversold, but the current price range of the EUR/USD may be seen as fair market equilibrium for the time being. "
  • Eur/usd price analysis: extends losses to near 1.0830 followed by the monthly low. According to FXStreet on Friday, 26 January, "Additionally, the lagging indicator, Moving Average Convergence Divergence (MACD), for the EUR/USD pair signals a potential confirmation of a downward trend. ", "The EUR/USD pair experienced downward pressure following the release of Gross Domestic Product (GDP) data from the United States (US)."
  • Eur/usd recovers near-term losses, but gains capped post-us PCE. According to FXStreet on Friday, 26 January, "Dollar bets continue to weigh on USD pairs, keeping EUR/USD leaning toward a near-term middle around 1.0850.", "Despite intraday tests into the low side, EUR/USD is set to continue languishing in an ongoing congestion pattern between the 50-day and 200-day SMAs at 11.0925 and 1.0850, respectively. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com